Molbio Diagnostics IPO GMP is ₹132. If this trend continues, the listing price is expected to be close to ₹939.00 [16.35%]. However, investors are advised to focus on the company’s fundamentals rather than relying solely on gray market fluctuations.
As a reminder, trading in the Molbio Diagnostics IPO GMP has begun. Further changes to the GMP will provide a clearer picture of potential listing trends. We update the Molbio Diagnostics IPO GMP daily, so stay tuned for the latest GMP, price trends, and potential listing price.
Molbio Diagnostics IPO of 1,16,46,246 equity shares of the face value of ₹1 aggregating up to ₹939.70 Crores. The IPO issue priced at ₹768 to ₹807 per share. The IPO will open on August 10, 2026 and will close on August 12, 2026.
Molbio Diagnostics IPO GMP Trend [Day Wise]
The Molbio Diagnostics IPO GMP prices shown here are only news related to the grey market. We do not trade/deal in the grey market or under the rates, and not do we recommend trading in the grey market.
Molbio Diagnostics IPO Daily GMP Live Trends…
| Date/Update | Price | GMP | SSR | ELP |
|---|---|---|---|---|
| 10/08/2026 (23:00) | ₹807 | ₹132 | 1700 | ₹939.00 [16.36%] |
| 09/08/2026 (23:00) | ₹807 | ₹132 | 1700 | ₹939.00 [16.36%] |
Read Also: Molbio Diagnostics IPO Subscription Data
For your information, the IPO GMP is subject to extreme volatility. Making an investment decision based solely on the Molbio Diagnostics IPO GMP can be risky. Please consider all factors before investing in the Molbio Diagnostics IPO.
Molbio Diagnostics IPO GMP Disclaimer
- GMP is not an indicator of the final listing price: GMP is only a reflection of the demand and supply of IPO shares in the grey market. The final listing price will depend on a number of factors, including overall market sentiment and the company’s performance in the post-IPO period.
- GMP can be volatile: GMP can fluctuate significantly in the days leading up to the XYZ IPO listing. This is due to uncertainty over the final listing price and the volatility of the stock market in general.
- There is no guarantee of profit: Even if the GMP is high, there is no guarantee that the XYZ IPO shares will list at a profit. The final listing price may be lower than the GMP, or the value of the shares may decline after listing.
- Investing in IPOs is risky: IPO are considered to be high-risk investments. There is always a possibility that the company may fail, or the shares may underperform in the future.
Molbio Diagnostics IPO GMP FAQs
What is the Grey Market Premium (GMP) of Molbio Diagnostics IPO today?
The Grey Market Premium (GMP) of Molbio Diagnostics IPO today is ₹132.
What is Molbio Diagnostics IPO Expected Returns?
The Molbio Diagnostics IPO Expected Returns is 16.36%.
When will the allotment for the Molbio Diagnostics IPO be finalized?
The Molbio Diagnostics IPO allotment is expected to be finalized on August 13, 2026.
When will the shares of Molbio Diagnostics IPO get listed?
The IPO shares are expected to be listed on the BSE and NSE on August 17, 2026.
Disclaimer: Readers are strongly advised to seek guidance from a qualified financial advisor before making any investment decisions. Relying solely on the content presented here for financial choices is done entirely at the reader’s own risk.
| Thank You… |
|---|
Share the post "Molbio Diagnostics IPO GMP Today, Latest Grey Market Premium 2026"